Abstract
Our analysis of drug use and morbidity data from a cohort of 1034 men yields the following results: 1) HIV infection is a strong indicator of drug use — HIV-positive respondents reported an average lifetime dose of recreational drugs (excluding marijuana) 2.3 times higher than HIV-negative respondents. 2) Homosexuality is a strong indicator of drug use — homosexual respondents reported an average lifetime dose 2.0 times higher than heterosexual respondents. 3) The incidence of AIDS-defining diseases was not limited to respondents infected with HIV, but was almost completely limited (98%) to respondents who reported using drugs. We also address a previous report (Ascher et al., 1993) that was based on the same database and purported to show that HIV alone correlates with the development of AIDS. Specifically, we show that the relationship between HIV infection and CD4+ T Cell loss is weaker than reported by Ascher et al., and provides little evidence for a causative relationship. These results support the hypothesis that long-term, habitual drug use can cause the conditions known as AIDS (independent of the presence of HIV), and refute the hypothesis that HIV alone causes these conditions independent of drug use.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Ascher, M.S., H.W. Sheppard, J. Winkelstein, & E. Vittinghoff, 1993. Does drug use cause AIDS? Nature (London) 362: 103–4.
Centers for Disease Control, 1987. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. J. Am. Med. Assoc. 258: 1143–1154.
Centers for Disease Control, 1993. HIV/AIDS Surveillance; yearend edition. February Issue.
Centers for Disease Control and Prevention, 1992. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb. Mort. Weekly Rep. 41: 1–19.
Duesberg, P., 1992. AIDS acquired by drug consumption and other noncontagious risk factors. Pharmacology & Therapeutics 55: 201–277.
Duesberg, P.H., 1992. AIDS Acquired by Drug Consumption and Other Noncontagious Risk Factors, Pharmac. Ther. Vol. 55 pp. 201–277.
Duesberg, P., 1993a. The HIV gap in national AIDS statistics. Biotechnology 11: 955–956.
Duesberg, P.H., 1993b. Can epidemiology determine whether drugs or HIV cause AIDS? AIDS-Forschung 12: 627–635.
Friedman-Kien, A.E., B.R. Saltzman, Y. Cao, M.S. Nestor, M. Mirabile, J.J. Li & T.A. Peterman, 1990. Kaposi’s sarcoma in HIV-negative homosexual men. Lancet 335: 168–169.
Haverkos, H.W., 1988. Epidemiologic studies-Kaposi’s sarcoma vs. opportunistic infections among homosexual men with AIDS. In: Health Hazards of Nitrite Inhalants, Research Monograph 83, pp. 96–105, H.W. Haverkos & J.A. Dougherty (eds.) National Institute on Drug Abuse, Rockville, MD.
Haverkos, H.W. & J.A. Dougherty (eds) (1988) Health Hazards of Nitrite Inhalants. NIDA Research Monograph 83, National Institute on Drug Abuse, Washington DC.
Holt, P.G., L.M. Finlay-Jones, D. Keast & J.M. Papadimitrou, 1979. Immunological function in mice chronically exposed to nitrogen dioxide (NO2). Environmental Research 19: 154–162.
Institute of Medicine and National Academy of Sciences, 1986. Confronting AIDS. National Academy Press, Washington, DC.
Jaffe, H.W., K. Choi, P.A. Thomas, H.W. Haverkos, D.M. Auerbach, M.E. Guinan, M.F. Rogers et al., 1983. National case-control study of Kaposi’s sarcoma and Pneumocystic carinii pneumonia in homosexual men: Part 1, epidemiologic results. Ann, Intern. Med. 99:145–151.
Lang, W., R.E. Anderson, H. Perkins, R.M. Grant, D. Lyman, W. Winkelstein, R. Royce & J.A. Levy, 1987. Clinical, immunologic, and serologic findings in men at risk for Acquired Immunodeficiency Syndrome. J. Am. Med. Assoc. 257: 326–330.
Lauritsen, J. & H. Wilson, 1986. Death Rush, Poppers and AIDS. Pagan Press, New York.
Murray, H.W., D.A. Scavuzzo, C.D. Kelly, B.Y. Rubin & R.B. Roberts, 1988. T4+ cell production of interferon gamma and the clinical spectrum of patients at risk for and with acquired immunodeficiency syndrome. Arch. Intern. Med. 148: 1613–1616.
Newell, G.R., M.R. Spitz & M.B. Wilson, 1988. Nitrite inhalants: Historical perspective. In: Health Hazards of Nitrite Inhalants, Research Monograph 83, pp. 1–14, H.W. Haverkos and J.A. Dougherty (eds.) National Institute of Drug Abuse, Rockville, MD.
Ortiz, J.S. & V.L. Rivera, 1988. Altered T-cell helper/suppressor ratio in mice chronically exposed to amyl nitrite. In: Health Hazards of Nitrite Inhalants, Research Monograph 83, pp. 59–74, H.W. Haverkos and J.A. Dougherty (eds.) National Institute on Drug Abuse, Rockville, MD.
Schechter, M.T., K.J.P. Craib, K.A. Gelmon, J.S.G. Montaner, T.N. Le & M.V. O’Shaughnessy, 1993. HIV-1 and the aetiology of AIDS. The Lancet 341: 658–659.
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers
About this chapter
Cite this chapter
Ellison, B.J., Downey, A.B., Duesberg, P.H. (1996). HIV as a surrogate marker for drug use: a re-analysis of the San Francisco Men’s Health Study. In: Duesberg, P.H. (eds) AIDS: Virus- or Drug Induced?. Contemporary Issues in Genetics and Evolution, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1651-7_6
Download citation
DOI: https://doi.org/10.1007/978-94-009-1651-7_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-3961-8
Online ISBN: 978-94-009-1651-7
eBook Packages: Springer Book Archive